/

Research

A Brief History of MDMAShutterstock

A Brief History of MDMA: From the CIA to Raves to Psychedelic Therapy

,
The history of MDMA is fascinating, and it is still being written.
MindMed's Phase 2 LSD Trial Treating Anxiety Was a SuccessShutterstock

MindMed’s Phase 2 LSD Trial Treating Anxiety Was a Success

Researchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients.
Shutterstock

Compass Pathways Shares ‘Promising’ Data That Psilocybin May Treat Anorexia

There is currently no FDA-approved treatment for anorexia. Could psychedelics be the answer?
Shutterstock

Fungus Among Us: 5 Fascinating Facts About Mushrooms

Science just keeps discovering how cool and beneficial mushrooms are, with or without psilocybin.
MAPS Navigates Multiple Scandals: Why Health Canada Is Reviewing MDMA TrialsShutterstock

MAPS Navigates Multiple Scandals: Why Health Canada Is Reviewing MDMA Trials

A sexual misconduct scandal, a data scandal, and an elder abuse scandal haunt psychedelics leader MAPS, currently being scrutinized by Health Canada.
Psilocybin Study Links Psychedelics to Lower Risk of Opioid AddictionShutterstock

New Study Links Psilocybin to Lower Risk of Opioid Addiction

Researchers attempt to replicate findings from a 2017 study that found classic psychedelic use conferred reduced risk of past-year opioid dependence and abuse.
Shutterstock

Mushrooms Have Their Own Language, New Study Suggests

The electric pulses could be organized into “trains” that resemble human words, and a vocabulary of “up to 50 words” appears to be present.
How to Enroll in a Psychedelic Clinical Trial in 5 Easy StepsShutterstock

How to Enroll in a Psychedelic Clinical Trial in 5 Easy Steps

Interested in participating in a psychedelic study? Here's an in-depth walk through guide so you can take actionable steps to make it happen.
5 Most Important Psychedelic Clinical Trials of 2022Shutterstock

5 Most Important Psychedelic Clinical Trials in 2022

Here's why we think MAPS’ second Phase 3 MDMA trial is the most important psychedelic study of 2022, and 4 more that may have huge impacts.

© 2022 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.